Centene Osake

Centene EBITDA

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Centene (CNC) 12.8.2026 päivämäärällä on −6,34 Mrd. USD. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli 5,12 Mrd. USD — muutos −223,94 % (matalampi).

EBITDA

−6,34 Mrd.USD

YoY

−223,94%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Centene on 2026 −6,34 Mrd. USD. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Centene oli 2025 5,12 Mrd. USD. Se laskee −223,94% matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Centene Osakeanalyysi

Mitä Centene tekee? The Centene Corporation is a leading provider of managed care and health insurance programs in the USA. The company is headquartered in St. Louis, Missouri and was founded in 1984. In recent years, it has experienced remarkable expansion and operates in many states across the USA. Business model: Centene operates a business model that focuses on managed care, meaning integrated healthcare systems where services from physicians, hospitals, and other healthcare facilities are bundled together. By bundling services, Centene can better control costs and improve the quality of healthcare. The company offers health insurance for both low-income individuals, such as Medicaid, as well as higher-income individuals. Different divisions: Centene Corp is divided into several divisions to be able to offer different types of insurance. One of the most important is Medicaid, the government health program for low-income individuals. Centene is the largest provider of Medicaid programs in the USA and has managed to establish a strong presence in many states. In addition to Medicaid, Centene also operates managed care programs for higher-income individuals, such as through partnerships with employers or through health insurance marketplaces. Products: In addition to basic health insurance products, Centene also offers specialized insurance programs tailored to the needs of individuals with specific health problems. This includes programs for individuals with diabetes, mental illnesses, or addictions. These programs offer better and specific treatment for these conditions, contributing to improved healthcare. Conclusion: Overall, Centene is one of the largest and fastest-growing companies in the US healthcare industry and plays an important role in providing health insurance in the USA. The company has developed a successful business model that focuses on managed care and offers a wide range of products to meet the diverse needs of customers. With a smart business strategy and a continuous focus on innovation and quality, Centene is a significant force in the healthcare sector in the United States of America. Centene on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Centene osakkeesta

Yhtiön Centene EBITDA (Tulos ennen korkoja, veroja ja poistoja) on −6,34 Mrd. USD vuonna 2026.

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Centene muuttui arvosta 5,12 Mrd. USD arvoon −6,34 Mrd. USD, mikä edustaa −223,94 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBITDA (Tulos ennen korkoja, veroja ja poistoja) Centene:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA mittaa operatiivista suorituskykyä ennen rahoitusrakenteen, veroympäristön ja muiden kuin käteispoisto-osuuksien vaikutusta.

EBITDA = EBIT + Poistot

EBITDA (Tulos ennen korkoja, veroja ja poistoja):n USD on sijoittajille tärkeä tekijä. Muutokset tässä tunnusluvussa voivat signaloida parantuvia tai heikentyneitä perustekijöitä, mikä vaikuttaa suoraan osakekurssiin. Eulerpoolissa voit seurata EBITDA (Tulos ennen korkoja, veroja ja poistoja):n Centene historiallisesti ja reaaliajassa.

Access this data via the Eulerpool API

Tuloslaskelma — Centene

Kaikki tunnusluvut — Centene